Posted by Michael Wonder on 15 Mar 2017
Can a statistical method speed drug approvals?
13 March 2017 - Not likely, says F. Perry Wilson, MD.
A study appearing in PLOS ONE suggests that a statistic called the Bayes factor can keep the FDA from approving useless drugs. But, MedPage Today reviewer F. Perry Wilson, MD, argues that it won't; vigorous defense of the agency's regulatory powers, on the other hand, will.
The long-running cold war between frequentist and Bayesian statisticians got a bit hotter with the publication of this article, appearing in PLOS ONE.
